- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2092-6413
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Immune checkpoint inhibitors: recent progress and potential biomarkers ; volume:50 ; number:12 ; day:13 ; month:12 ; year:2018 ; pages:1-11 ; date:12.2018
Experimental & molecular medicine ; 50, Heft 12 (13.12.2018), 1-11, 12.2018
- Creator
-
Darvin, Pramod
Toor, Salman M.
Sasidharan Nair, Varun
Elkord, Eyad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s12276-018-0191-1
- URN
-
urn:nbn:de:101:1-2019021421470654516495
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Darvin, Pramod
- Toor, Salman M.
- Sasidharan Nair, Varun
- Elkord, Eyad
- SpringerLink (Online service)
Other Objects (12)
Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli—an Industry Perspective
Recent progress and perspectives on prostate cancer biomarkers
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
Identification of immune biomarkers in recent active pulmonary tuberculosis
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?
Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli—an Industry Perspective
Recent progress and perspectives on prostate cancer biomarkers
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
Identification of immune biomarkers in recent active pulmonary tuberculosis
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?
Recent Progress of Potentiating Immune Checkpoint Blockade with External Stimuli—an Industry Perspective
Recent progress and perspectives on prostate cancer biomarkers
Microbial biomarkers for immune checkpoint blockade therapy against cancer
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
Identification of immune biomarkers in recent active pulmonary tuberculosis
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments